产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
应用
Reactant involved in the synthesis of biologically active molecules including:
- 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands
- Pyrimidinyl purinediones via cyclocondensation
- Theophylline derivatives as adenosine receptor antagonists
- Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors
- Fused tricyclic xanthines
- Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAC4559 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
经验(实验)分子式 | C6H10N4O2 · xH2O |
分子量 | 170.17 (anhydrous basis) |
Beilstein | 157451 |
MDL编号 | MFCD00149431 |
产品性质
等级 | certified reference material pharmaceutical secondary standard |
形式 | solid |
包装 | pkg of 100 mg |
mp | 210-214 ℃ (dec.) (lit.) |
储存温度 | 2-30℃ |
SMILES string | O.CN1C(N)=C(N)C(=O)N(C)C1=O |
InChI | 1S/C6H10N4O2.H2O/c1-9-4(8)3(7)5(11)10(2)6(9)12;/h7-8H2,1-2H3;1H2 |
InChI key | FNLDCZCNGSQKIC-UHFFFAOYSA-N |